Updated Timeline for the Clinical Trial Regulation
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Medicines Agency, EMA, is still planning with January 2022 for the go-live date of the EU Clinical Trials Information System (CTIS) database and portal, and thus with the first application of the Clinical Trial Regulation (CTR, Regulation (EU) No 536/2014).
The Clinical Trials Regulation (CTR) has been in force since 2014. The date of its first application depends on the full functionality of the CTIS being confirmed by an independent audit. The CTR will become applicable six months after the publication of this confirmation by the European Commission (EC) in the Official Journal of the European Union.
The EMA will first review the findings of the system audit (Q4 2020). Subsequently, the usability, quality and stability of the CTIS will be improved and, at the same time, information will be provided to the users. In addition, a so-called Minimum Viable Product (MVP) is to be worked on together with the Member States. However, the contents (i.e. defined core functions of the CTIS) still have to be defined.
On their website, the EMA has published an update on the process of further activities after the audit.
Related GMP News
04.02.2026When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
27.01.2026New Ph. Eur. Publication Schedule
21.01.2026EU Pharma Package: EMA with single Point of Information
14.01.2026European QP Association Developments September through December 2025
14.01.2026Could a change of ownership be relevant to GMP?
07.01.2026Is QP Certification required when Products do not enter EU Territory?